The IMARC Group's latest research report, titled “Oral Proteins and Peptides Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the oral proteins and peptides market insights. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Oral Proteins and Peptides Market Trends:
The growing prevalence of chronic diseases such as diabetes and cancer are driving the global market. Moreover, the rising awareness among healthcare providers and patients about the benefits of oral administration over injections contributes to market growth. Moreover, the growing elderly population, which requires more manageable medication forms, fuels demand. Furthermore, extensive research and development investments by pharmaceutical companies to develop innovative products propel the market expansion. Additionally, favorable regulatory frameworks and expedited approval processes encourage the introduction of new therapies. The increasing adoption of personalized medicine and tailored treatment regimens based on genetic profiles further augments market growth.
Get Sample Copy of Report at – www.imarcgroup.com/oral-proteins-peptides-market/requestsample
Oral Proteins and Peptides Market Scope & Growth Analysis:
The scope of the global market is expanding due to continuous advancements in biotechnology and molecular engineering. Increasing healthcare expenditures and government funding for biopharmaceutical research significantly contribute to the market. The market also benefits from the rising trend of outsourcing drug development and manufacturing processes to specialized contract research and manufacturing organizations, which accelerates product development timelines. Furthermore, the integration of advanced drug delivery systems, such as nanoparticles and microneedles, enhances the efficiency and patient compliance of oral therapies. Expanding global healthcare infrastructure, particularly in emerging economies, provides new opportunities for market penetration.
Competitive Landscape with Key Players:
Amryt Pharma Plc
AstraZeneca PLC
Biocon Limited
Novo Nordisk A/S
Oramed Ltd
Proxima Concepts Limited
Key Market Segmentation:
Drug Type Insights:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
Application Insights:
Gastric and Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
Why Choose IMARC Research Report:
Strong Market Research Expertise
Targeted Marketing Strategies
Innovative Solutions
Comprehensive Analysis
Accuracy and Reliability
Provides Insightful Forecasts
Available Customization Options
Strong Customer Service